These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Detection of anti-aquaporin 4 antibody in neuromyelitis optical]. Liao ZY; Ye J; Sun H; You XF; Guan YQ Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):1012-5. PubMed ID: 23886267 [TBL] [Abstract][Full Text] [Related]
25. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Ishii N; Itoyama Y Tohoku J Exp Med; 2006 Dec; 210(4):307-13. PubMed ID: 17146196 [TBL] [Abstract][Full Text] [Related]
26. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Min JH; Kim HJ; Kim BJ; Lee KW; Sunwoo IN; Kim SM; Kim BJ; Kim SH; Park MS; Waters P; Vincent A; Sung JJ; Lee KH Mult Scler; 2009 Sep; 15(9):1069-76. PubMed ID: 19625331 [TBL] [Abstract][Full Text] [Related]
28. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients. Ketelslegers IA; Modderman PW; Vennegoor A; Killestein J; Hamann D; Hintzen RQ Mult Scler; 2011 Dec; 17(12):1527-30. PubMed ID: 21828202 [TBL] [Abstract][Full Text] [Related]
29. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations. Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545 [TBL] [Abstract][Full Text] [Related]
30. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993 [TBL] [Abstract][Full Text] [Related]
31. Neuromyelitis optica and asian phenotype of multiple sclerosis. Kira J Ann N Y Acad Sci; 2008 Oct; 1142():58-71. PubMed ID: 18990121 [TBL] [Abstract][Full Text] [Related]
32. Multimodality-evoked potential study of anti-aquaporin-4 antibody-positive and -negative multiple sclerosis patients. Watanabe A; Matsushita T; Doi H; Matsuoka T; Shigeto H; Isobe N; Kawano Y; Tobimatsu S; Kira J J Neurol Sci; 2009 Jun; 281(1-2):34-40. PubMed ID: 19339021 [TBL] [Abstract][Full Text] [Related]
33. [New insights into the pathogenesis of neuromyelitis optica]. Misu T; Takahashi T; Nishiyama S; Takano R; Nakashima I; Fujihara K; Itoyama Y Brain Nerve; 2010 Sep; 62(9):921-31. PubMed ID: 20844303 [TBL] [Abstract][Full Text] [Related]
35. [Neuromyelitis optica: the disease entity, pathogenesis and therapy]. Fujihara K Rinsho Shinkeigaku; 2007 Nov; 47(11):883-5. PubMed ID: 18210826 [TBL] [Abstract][Full Text] [Related]
36. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579 [TBL] [Abstract][Full Text] [Related]
37. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane. Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518 [TBL] [Abstract][Full Text] [Related]